NOVARTIS AG-SPONSORED ADR
NVS · NYSE
Updated at 2026-10-14 10:31:51
- Today's High
- $145.24
- Today’s Low
- $142.31
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $143.84
- Previous Close
- $143.84
- Volume
- 1.14M
- Market Cap
- $218.01B
- P/E Ratio
- 20.51X
- EPS
- $6.62
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- DRUG MANUFACTURERS - GENERAL
- Headquarters
- LICHTSTRASSE 35, BASEL, SWITZERLAND, 4056
- Country
- CH
- Listing Date
- 2001-05-07
- Fiscal Year End
- December
- Shares Outstanding
- 2.03B
- CIK
- 0001114448
- Website
- www.novartis.com
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
Financial Metrics
Revenue
2026-06-30
$14.41B
2026-03-31
$13.52B
2025-12-31
$13.33B
2025-09-30
$14.35B
Operating Expenses
2026-06-30
$6B
2026-03-31
$5.83B
2025-12-31
$6.27B
2025-09-30
$6.31B
Net Income
2026-06-30
$3.26B
2026-03-31
$3.15B
2025-12-31
$2.4B
2025-09-30
$3.92B
Net Profit Margin
2026-06-30
22.65%
2026-03-31
23.33%
2025-12-31
18.06%
2025-09-30
27.35%
Earnings Per Share
2026-06-30
$2.41
2026-03-31
$1.65
2025-12-31
$2.03
2025-09-30
$2.25
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$5.93B
2026-03-31
$5.41B
2025-12-31
$5.07B
2025-09-30
$5.84B
Effective Tax Rate
2026-06-30
23.7%
2026-03-31
17.79%
2025-12-31
25.29%
2025-09-30
6.33%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $14.41B | $13.52B | $13.33B | $14.35B |
| Operating Expenses | $6B | $5.83B | $6.27B | $6.31B |
| Net Income | $3.26B | $3.15B | $2.4B | $3.92B |
| Net Profit Margin | 22.65% | 23.33% | 18.06% | 27.35% |
| Earnings Per Share | $2.41 | $1.65 | $2.03 | $2.25 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $5.93B | $5.41B | $5.07B | $5.84B |
| Effective Tax Rate | 23.7% | 17.79% | 25.29% | 6.33% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.